UK BREXIT – eCTD BASELINE for Converting CAPs into UK MAs

The North Face The North Face 20ss Scoop Jacket NP61940 KW Black White L from Stylish Anglers

9 October 2020

BlueReg

From 1 January 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) will be the UK’s stand-alone medicines and medical devices regulator.

 

In this context MHRA has released the following guidance – “Converting Centrally Authorised Products (CAPs) to UK Marketing Authorisations (MAs) from 1 January 2021, 'grandfathering' and managing lifecycle changes” focused on:

BlueReg Support

 

In this context, BlueReg has already worked on the guidance and set up the support and solutions so that its clients can convert their procedures from centralized procedures to National MAs while limiting the impact on their business as much as possible.

 

Thus, BlueReg can help you on:

 

 

BlueReg

Did you like this article? Share on social networks:

Associated News

eCTD Format Mandatory for EU National Procedures

After CP, DCP/MRP Procedures, and according to the eSubmissions Roadmap Timelines, eCTD format is now...

Download now

BlueReg’s team will be pleased to meet you at RAPS Regulatory Convergence, booth 612A

BlueReg’s team will be pleased to meet you at RAPS Regulatory Convergence, booth 612A  ...

Download now

BlueReg’s team will be pleased to meet you at BioFit Lille, on booth F10

Event location: Lille, France  Event date: Tuesday, December 4, 2018 to Wednesday, December 5, 2018 ...

Download now